FDA recall, , Moderate risk
Versiti Blood Health Red Blood Cells, Leukocytes Reduced
Red Blood Cells, Leukocytes Reduced, quarantined due to possible hemolysis, were distributed prior to completion of the investigation.
Versiti Blood Health began this recall on Oct 17, 2025. FDA posted it on Nov 12, 2026, the day the recall ended.
What happened
Versiti Blood Health, Inc., of Indianapolis, Indiana, is recalling its Red Blood Cells, Leukocytes Reduced. The recall is due to possible hemolysis. The company started the recall on its own on October 17, 2025, and told customers by telephone. The FDA classified the recall on November 12, 2026.
What to do
Biologics such as blood, tissue and vaccines are usually given by hospitals and clinics. If you had a transfusion, transplant, infusion or vaccine, ask the place that treated you whether this product was used. If they contact you, follow their advice.
What was recalled
Hospitals, clinics and blood banks match these details against their records.
Red Blood Cells, Leukocytes Reduced
- Unit number
- W040725559077
Recall details
- Posted by FDA
- Recall began
- Status
- Ended Nov 12, 2026
- Weekly archive
- Listed the week of Nov 9, 2026
- Distributed to
- Recalled by
- Versiti Blood Health, IncIndianapolis, Indiana
- Risk
Moderate risk
Its use may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.
FDA Class II recall · How risk is rated
- FDA event number
- 100249
- Recall number
- B-0030-2027
- Recall type
- Started by the company
- How the company first told customers
- Phone
All recalls from Versiti Blood Health, Inc
Timeline
FDA's Enforcement Report is its public list of recalls; FDA posts a recall by adding it there.
Versiti Blood Health began the recall
FDA posted the recall to its Enforcement Report, rated it Class II (moderate risk) and closed it
Added to Recall Canary
